药品审批更新。
Pharmaceutical approval update.
作者信息
Goldenberg Marvin M
出版信息
P T. 2008 May;33(5):299-302.
Abstract
Topics include bendamustine (Treanda) for chronic lymphocytic leukemia, hepatitis B immune globulin (HepaGam B) to prevent hepatitis B infection following liver transplantation, and a fibrin sealant (Artiss) used in skin graft surgery for burn patients.
摘要
主题包括用于慢性淋巴细胞白血病的苯达莫司汀（Treanda）、用于预防肝移植后乙型肝炎感染的乙型肝炎免疫球蛋白（HepaGam B），以及用于烧伤患者皮肤移植手术的纤维蛋白密封剂（Artiss）。
相似文献
1
Pharmaceutical approval update.
P T. 2008 May;33(5):299-302.
2
Artiss® and burn treatment: a retrospective analysis contributing to current clinical practice.
Int J Burns Trauma. 2020 Apr 15;10(2):21-27. eCollection 2020.
3
Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
Clin Ther. 2009;31 Pt 2:2290-311. doi: 10.1016/j.clinthera.2009.11.031.
4
Treanda approved for chronic lymphocytic leukemia.
Am J Health Syst Pharm. 2008 May 1;65(9):793. doi: 10.2146/news080034.
5
Fibrin sealant improves graft adherence in a porcine full-thickness burn wound model.
Burns. 2011 Dec;37(8):1360-6. doi: 10.1016/j.burns.2009.08.011. Epub 2011 May 6.
6
Artiss Sealant®: An Alternative to Stapling Skin Grafts on the Dorsal Side of the Hand and Fingers.
J Burn Care Res. 2017 Sep/Oct;38(5):283-289. doi: 10.1097/BCR.0000000000000503.
7
Fibrin tissue sealant and minor skin grafts in burn surgery: A systematic review and meta-analysis.
J Plast Reconstr Aesthet Surg. 2019 Jun;72(6):871-883. doi: 10.1016/j.bjps.2018.12.036. Epub 2019 Jan 8.
8
Efficacy and safety of a fibrin sealant for adherence of autologous skin grafts to burn wounds: results of a phase 3 clinical study.
J Burn Care Res. 2008 Mar-Apr;29(2):293-303. doi: 10.1097/BCR.0b013e31816673f8.
9
Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation.
Liver Transpl. 2003 Feb;9(2):182-7. doi: 10.1053/jlts.2003.50002.
10
A multicenter clinical trial to evaluate the topical hemostatic efficacy of fibrin sealant in burn patients.
J Burn Care Rehabil. 2001 Mar-Apr;22(2):99-103. doi: 10.1097/00004630-200103000-00003.
引用本文的文献
1
Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review.
J Immunol Res. 2015;2015:968212. doi: 10.1155/2015/968212. Epub 2015 Dec 16.
2
A fusion protein derived from Moraxella catarrhalis and Neisseria meningitidis aimed for immune modulation of human B cells.
Hum Vaccin Immunother. 2015;11(9):2223-7. doi: 10.1080/21645515.2015.1034917. Epub 2015 Jun 4.
3
Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all!
Bone Marrow Transplant. 2014 May;49(5):599-606. doi: 10.1038/bmt.2013.226. Epub 2014 Jan 20.
4
Histologic evaluation of absorbable and non-absorbable barrier coated mesh secured to the peritoneum with fibrin sealant in a New Zealand white rabbit model.
Hernia. 2011 Dec;15(6):677-84. doi: 10.1007/s10029-011-0834-9. Epub 2011 May 24.
5
Evaluation of intraperitoneal placement of absorbable and nonabsorbable barrier coated mesh secured with fibrin sealant in a New Zealand white rabbit model.
Surg Endosc. 2011 Feb;25(2):604-12. doi: 10.1007/s00464-010-1230-8. Epub 2010 Jul 22.
6
Evaluation of acute fixation strength of absorbable and nonabsorbable barrier coated mesh secured with fibrin sealant.
Hernia. 2010 Oct;14(5):505-9. doi: 10.1007/s10029-010-0670-3. Epub 2010 May 9.
Zotero 插件